Matthew Moore
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matthew Moore.
Human Molecular Genetics | 2011
Dena Hernandez; Michael A. Nalls; J. Raphael Gibbs; Sampath Arepalli; Marcel van der Brug; Sean Chong; Matthew Moore; Dan L. Longo; Mark R. Cookson; Bryan J. Traynor; Andrew Singleton
Methylation at CpG sites is a critical epigenetic modification in mammals. Altered DNA methylation has been suggested to be a central mechanism in development, some disease processes and cellular senescence. Quantifying the extent and identity of epigenetic changes in the aging process is therefore potentially important for understanding longevity and age-related diseases. In the current study, we have examined DNA methylation at >27,000 CpG sites throughout the human genome, in frontal cortex, temporal cortex, pons and cerebellum from 387 human donors between the ages of 1 and 102 years. We identify CpG loci that show a highly significant, consistent correlation between DNA methylation and chronological age. The majority of these loci are within CpG islands and there is a positive correlation between age and DNA methylation level. Lastly, we show that the CpG sites where the DNA methylation level is significantly associated with age are physically close to genes involved in DNA binding and regulation of transcription. This suggests that specific age-related DNA methylation changes may have quite a broad impact on gene expression in the human brain.
Neurobiology of Disease | 2012
Dena Hernandez; Michael A. Nalls; Matthew Moore; Sean Chong; Allissa Dillman; Daniah Trabzuni; J. Raphael Gibbs; Mina Ryten; Sampath Arepalli; Michael E. Weale; Alan B. Zonderman; Juan C. Troncoso; Richard O'Brien; Robert P. Walker; Colin Smith; Stefania Bandinelli; Bryan J. Traynor; John Hardy; Andrew Singleton; Mark R. Cookson
Genome-wide association studies have nominated many genetic variants for common human traits, including diseases, but in many cases the underlying biological reason for a trait association is unknown. Subsets of genetic polymorphisms show a statistical association with transcript expression levels, and have therefore been nominated as expression quantitative trait loci (eQTL). However, many tissue and cell types have specific gene expression patterns and so it is not clear how frequently eQTLs found in one tissue type will be replicated in others. In the present study we used two appropriately powered sample series to examine the genetic control of gene expression in blood and brain. We find that while many eQTLs associated with human traits are shared between these two tissues, there are also examples where blood and brain differ, either by restricted gene expression patterns in one tissue or because of differences in how genetic variants are associated with transcript levels. These observations suggest that design of eQTL mapping experiments should consider tissue of interest for the disease or other traits studied.
Proceedings of the National Academy of Sciences of the United States of America | 2010
Roberto A. Chica; Matthew Moore; Benjamin D. Allen; Stephen L. Mayo
The longer emission wavelengths of red fluorescent proteins (RFPs) make them attractive for whole-animal imaging because cells are more transparent to red light. Although several useful RFPs have been developed using directed evolution, the quest for further red-shifted and improved RFPs continues. Herein, we report a structure-based rational design approach to red-shift the fluorescence emission of RFPs. We applied a combined computational and experimental approach that uses computational protein design as an in silico prescreen to generate focused combinatorial libraries of mCherry mutants. The computational procedure helped us identify residues that could fulfill interactions hypothesized to cause red-shifts without destabilizing the protein fold. These interactions include stabilization of the excited state through H-bonding to the acylimine oxygen atom, destabilization of the ground state by hydrophobic packing around the charged phenolate, and stabilization of the excited state by a π-stacking interaction. Our methodology allowed us to identify three mCherry mutants (mRojoA, mRojoB, and mRouge) that display emission wavelengths > 630 nm, representing red-shifts of 20–26 nm. Moreover, our approach required the experimental screening of a total of ∼5,000 clones, a number several orders of magnitude smaller than those previously used to achieve comparable red-shifts. Additionally, crystal structures of mRojoA and mRouge allowed us to verify fulfillment of the interactions hypothesized to cause red-shifts, supporting their contribution to the observed red-shifts.
Human Molecular Genetics | 2011
Andrew R. Wood; Dena Hernandez; Michael A. Nalls; Hanieh Yaghootkar; J. Raphael Gibbs; Lorna W. Harries; Sean Chong; Matthew Moore; Michael N. Weedon; Jack M. Guralnik; Stefania Bandinelli; Anna Murray; Luigi Ferrucci; Andrew Singleton; David Melzer; Timothy M. Frayling
The identification of multiple signals at individual loci could explain additional phenotypic variance (‘missing heritability’) of common traits, and help identify causal genes. We examined gene expression levels as a model trait because of the large number of strong genetic effects acting in cis. Using expression profiles from 613 individuals, we performed genome-wide single nucleotide polymorphism (SNP) analyses to identify cis-expression quantitative trait loci (eQTLs), and conditional analysis to identify second signals. We examined patterns of association when accounting for multiple SNPs at a locus and when including additional SNPs from the 1000 Genomes Project. We identified 1298 cis-eQTLs at an approximate false discovery rate 0.01, of which 118 (9%) showed evidence of a second independent signal. For this subset of 118 traits, accounting for two signals resulted in an average 31% increase in phenotypic variance explained (Wilcoxon P< 0.0001). The association of SNPs with cis gene expression could increase, stay similar or decrease in significance when accounting for linkage disequilibrium with second signals at the same locus. Pairs of SNPs increasing in significance tended to have gene expression increasing alleles on opposite haplotypes, whereas pairs of SNPs decreasing in significance tended to have gene expression increasing alleles on the same haplotypes. Adding data from the 1000 Genomes Project showed that apparently independent signals could be potentially explained by a single association signal. Our results show that accounting for multiple variants at a locus will increase the variance explained in a substantial fraction of loci, but that allelic heterogeneity will be difficult to define without resequencing loci and functional work.
Human Mutation | 2013
Arianna Tucci; Eleanna Kara; Anna Schossig; Nicole I. Wolf; Vincent Plagnol; Katherine Fawcett; Coro Paisán-Ruiz; Matthew Moore; Dena Hernandez; Sebastiano Musumeci; Michael B. Tennison; Raoul C. M. Hennekam; Silvia Palmeri; Alessandro Malandrini; Salmo Raskin; Dian Donnai; Corina Hennig; Andreas Tzschach; Roel Hordijk; Thomas Bast; Katharina Wimmer; Chien Ning Lo; Simon Shorvon; Mefford Hc; Evan E. Eichler; Roger K. Hall; Ian P. Hayes; John Hardy; Andrew Singleton; Johannes Zschocke
Kohlschütter–Tönz syndrome (KTS) is a rare autosomal recessive disorder characterized by amelogenesis imperfecta, psychomotor delay or regression and seizures starting early in childhood. KTS was established as a distinct clinical entity after the first report by Kohlschütter in 1974, and to date, only a total of 20 pedigrees have been reported. The genetic etiology of KTS remained elusive until recently when mutations in ROGDI were independently identified in three unrelated families and in five likely related Druze families. Herein, we report a clinical and genetic study of 10 KTS families. By using a combination of whole exome sequencing, linkage analysis, and Sanger sequencing, we identify novel homozygous or compound heterozygous ROGDI mutations in five families, all presenting with a typical KTS phenotype. The other families, mostly presenting with additional atypical features, were negative for ROGDI mutations, suggesting genetic heterogeneity of atypical forms of the disease.
PLOS ONE | 2012
Matthew Moore; Samuel K. Oteng-Pabi; Antonia T. Pandelieva; Stephen L. Mayo; Roberto A. Chica
Red fluorescent proteins (RFPs) derived from organisms in the class Anthozoa have found widespread application as imaging tools in biological research. For most imaging experiments, RFPs that mature quickly to the red chromophore and produce little or no green chromophore are most useful. In this study, we used rational design to convert a yellow fluorescent mPlum mutant to a red-emitting RFP without reverting any of the mutations causing the maturation deficiency and without altering the red chromophore’s covalent structure. We also created an optimized mPlum mutant (mPlum-E16P) that matures almost exclusively to the red chromophore. Analysis of the structure/function relationships in these proteins revealed two structural characteristics that are important for efficient red chromophore maturation in DsRed-derived RFPs. The first is the presence of a lysine residue at position 70 that is able to interact directly with the chromophore. The second is an absence of non-bonding interactions limiting the conformational flexibility at the peptide backbone that is oxidized during red chromophore formation. Satisfying or improving these structural features in other maturation-deficient RFPs may result in RFPs with faster and more complete maturation to the red chromophore.
PLOS ONE | 2015
Timothy M. Wannier; Matthew Moore; Yun Mou; Stephen L. Mayo
Computational design has been used with mixed success for the design of protein surfaces, with directed evolution heretofore providing better practical solutions than explicit design. Directed evolution, however, requires a tractable high-throughput screen because the random nature of mutation does not enrich for desired traits. Here we demonstrate the successful design of the β-sheet surface of a red fluorescent protein (RFP), enabling control over its oligomerization. To isolate the problem of surface design, we created a hybrid RFP from DsRed and mCherry with a stabilized protein core that allows for monomerization without loss of fluorescence. We designed an explicit library for which 93 of 96 (97%) of the protein variants are soluble, stably fluorescent, and monomeric. RFPs are heavily used in biology, but are natively tetrameric, and creating RFP monomers has proven extremely difficult. We show that surface design and core engineering are separate problems in RFP development and that the next generation of RFP markers will depend on improved methods for core design.
Human Mutation | 2013
Arianna Tucci; Eleanna Kara; Anna Schossig; Nicole I. Wolf; Vincent Plagnol; Katherine Fawcett; Coro Paisán-Ruiz; Matthew Moore; Dena Hernandez; Sebastiano Musumeci; Michael B. Tennison; Raoul C. M. Hennekam; Silvia Palmeri; Alessandro Malandrini; Salmo Raskin; Dian Donnai; Corina Hennig; Andreas Tzschach; Roel Hordijk; Thomas Bast; Katharina Wimmer; Chien-Ning Lo; Simon Shorvon; Mefford Hc; Evan E. Eichler; Roger K. Hall; Ian P. Hayes; John Hardy; Andrew Singleton; Johannes Zschocke
Kohlschütter–Tönz syndrome (KTS) is a rare autosomal recessive disorder characterized by amelogenesis imperfecta, psychomotor delay or regression and seizures starting early in childhood. KTS was established as a distinct clinical entity after the first report by Kohlschütter in 1974, and to date, only a total of 20 pedigrees have been reported. The genetic etiology of KTS remained elusive until recently when mutations in ROGDI were independently identified in three unrelated families and in five likely related Druze families. Herein, we report a clinical and genetic study of 10 KTS families. By using a combination of whole exome sequencing, linkage analysis, and Sanger sequencing, we identify novel homozygous or compound heterozygous ROGDI mutations in five families, all presenting with a typical KTS phenotype. The other families, mostly presenting with additional atypical features, were negative for ROGDI mutations, suggesting genetic heterogeneity of atypical forms of the disease.
Human Mutation | 2013
Arianna Tucci; Eleanna Kara; Anna Schossig; Nicole I. Wolf; Vincent Plagnol; Katherine Fawcett; Coro Paisán-Ruiz; Matthew Moore; Dena Hernandez; Sebastiano Musumeci; Michael B. Tennison; Raoul C. M. Hennekam; Silvia Palmeri; Alessandro Malandrini; Salmo Raskin; Dian Donnai; Corina Hennig; Andreas Tzschach; Roel Hordijk; Thomas Bast; Katharina Wimmer; Chien Ning Lo; Simon Shorvon; Mefford Hc; Evan E. Eichler; Roger K. Hall; Ian P. Hayes; John Hardy; Andrew Singleton; Johannes Zschocke
Kohlschütter–Tönz syndrome (KTS) is a rare autosomal recessive disorder characterized by amelogenesis imperfecta, psychomotor delay or regression and seizures starting early in childhood. KTS was established as a distinct clinical entity after the first report by Kohlschütter in 1974, and to date, only a total of 20 pedigrees have been reported. The genetic etiology of KTS remained elusive until recently when mutations in ROGDI were independently identified in three unrelated families and in five likely related Druze families. Herein, we report a clinical and genetic study of 10 KTS families. By using a combination of whole exome sequencing, linkage analysis, and Sanger sequencing, we identify novel homozygous or compound heterozygous ROGDI mutations in five families, all presenting with a typical KTS phenotype. The other families, mostly presenting with additional atypical features, were negative for ROGDI mutations, suggesting genetic heterogeneity of atypical forms of the disease.
Archive | 2011
Matthew Moore; Beverly Lu